2014China Modern MedicineRequires access

Effect observation of Shugan jieyu capsule in the treatment of post-stroke depression

Zeng Xiao-l

Open publisher page 0 citations

Abstract

Objective To investigate clinical effect of Shugan jieyu capsule in the treatment of post-stroke depression.Methods 82 cases of patients with post-stroke depression were selected as research objects and divided into observation group and control group by random number table method,each group of 41 cases.Shugan jieyu capsule was used in observation group,paroxetine hydrochloride tablet was used in control group.The clinical effect,SDS score and the incidence rate of complication was compared respectively between two groups. Results Total effective rate in observation group was 78.0%,higher than that in control group(56.1%),with statistical difference(P0.05).SDS score after treatment was lower than that before treatment in two groups respectively,SDS score after treatment in observation group was lower than that in control group,with statistical difference(P0.05).The incidence rate of complication in observation group was 7.3%,lower than that in control group(24.4%),with statistical difference(P0.05). Conclusion Shugan jieyu capsule in the treatment of post-stroke depression can improve clinical effect and SDS score,has high security,is worthy of clinical promotion and application.

About this research paper

What this paper is about

Objective To investigate clinical effect of Shugan jieyu capsule in the treatment of post-stroke depression.Methods 82 cases of patients with post-stroke depression were selected as research objects and divided into observation group and control group by random number table method,each group of 41 cases.Shugan jieyu capsule was used in observation group,paroxetine hydrochloride tablet was used in control group.The clinical effect,SDS score and the incidence rate of complication was compared respectively between two groups. Results Total effective rate in observation group was 78.0%,higher than that in control group(56.1%),with statistical difference(P0.05).SDS score after treatment was lower than that before treatment in two groups respectively,SDS score after treatment in observation group was lower than that in control group,with statistical difference(P0.05).The incidence rate of complication in observation group was 7.3%,lower than that in control group(24.4%),with statistical difference(P0.05). Conclusion Shugan jieyu capsule in the treatment of post-stroke depression can improve clinical effect and SDS score,has high security,is worthy of clinical promotion and application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate clinical effect of Shugan jieyu capsule in the treatment of post-stroke depression.Methods 82 cases of patients with post-stroke depression were selected as research objects and divided into observation group and control group by random number table method,each group of 41 cases.Shugan jieyu capsule was used in observation group,paroxetine hydrochloride tablet was used in control group.The clinical effect,SDS score and the incidence rate of complication was compared respectively between two groups. Results Total effective rate in observation group was 78.0%,higher than that in control group(56.1%),with statistical difference(P0.05).SDS score after treatment was lower than that before treatment in two groups respectively,SDS score after treatment in observation group was lower than that in control group,with statistical difference(P0.05).The incidence rate of complication in observation group was 7.3%,lower than that in control group(24.4%),with statistical difference(P0.05). Conclusion Shugan jieyu capsule in the treatment of post-stroke depression can improve clinical effect and SDS score,has high security,is worthy of clinical promotion and application.

Key concepts: Medicine, Depression (economics), Capsule, Incidence (geometry), Internal medicine, Stroke (engine), Post-stroke depression, Complication

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect observation of Shugan jieyu capsule in the treatment of post-stroke depression — Research Paper | ScholarLens